{
    "nctId": "NCT04438564",
    "briefTitle": "Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients",
    "officialTitle": "Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Colorectal Cancer, Cancer of Ovary, Cancer of Endometrium",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "The IL-2, TNF-alpha and IFN-gamma expression by traditional Chinese medicine treatment on cancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients diagnosed with ovarian cancer and endometrial cancer (cancer patients treated with chemotherapy, radiotherapy, and surgery) can be included.\n* Breast cancer: Diagnosed by pathological diagnosis of biopsy, without chemotherapy or radiotherapy.\n* Colorectal cancer: Diagnosed by pathological diagnosis of slices, without chemotherapy or radiotherapy.\n\nExclusion Criteria:\n\n* Pregnant women\n* Minors under the age of 20.\n* Those who are currently using traditional Chinese medicine",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}